Table 3 The outcome differences according to low dose steroid usages at 6 month and 12 month after graft failure in the subgroup analysis of immunosuppressant weaning group at 6 months after graft failure.
Steroid stopped 6 months after graft failure | Steroid maintaining 6 months after graft failure | P-values | Steroid stopped 12 months after graft failure | Steroid maintaining group 12 months after graft failure | P-values | |
|---|---|---|---|---|---|---|
Number of cases | 71 | 38 | 91 | 18 | ||
All-cause mortality (%) | 10 (14.1) | 1 (2.6) | 0.093 | 10 (11) | 1 (5.6) | 0.687 |
Immunosuppressant withdrawal preferred outcomes | ||||||
Hospitalization due to infection (%) | 24 (33.8) | 12 (31.6) | 0.983 | 29 (31.9) | 7 (38.9) | 0.761 |
Cancer (%) | 12 (16.9) | 5 (13.2) | 0.813 | 14 (15.4) | 3 (16.7) | 1.0 |
Immunosuppressant maintaining preferred outcomes | ||||||
Graft intolerance syndrome (%) | 8 (11.3) | 2 (5.2) | 0.489 | 9 (9.9) | 1 (5.6) | 1.0 |
Nephrectomy due to graft intolerance syndrome (%) | 8 (11.3) | 1 (2.6) | 0.158 | 9 (9.9) | 0 | 0.351 |
Re-transplantation (%) | 18 (25.4) | 7 (18.4) | 0.561 | 20 (22) | 5 (27.8) | 0.555 |
Diuretics usage duration after graft failure (months)a | 1 [0;11] | 9 [2;32] | 0.008 | 2 [0;9.5] | 25 [6;38] | 0.003 |
